Product Recall for Famvir® 500mg

HPS Pharmacies wish to give notice that Atnahs Pharma Australia, in consultation with the Therapeutic Goods Administration (TGA), has issued a product recall for Famvir^® tablets as follows:

Famvir^® 500mg Tablets, 30 pack
Famciclovir 500mg
ARTG 67391

This product recall was initiated as 30 tablet packs of Famvir^® 500mg have been found to contain two blisters of 10 tablets rather than the required three blisters of 10 tablets. This creates a theoretical risk of incomplete treatment for patients requiring the full 30 tablets.

The only batch affected by this notice is: WV100 (Expiry: Feb 2028)

Please inspect your stock and quarantine all affected products from the above batch. Affected products should be returned to the supplier for replacement stock.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact Atnahs Pharma Australia at [email protected] or your pharmacist at HPS Pharmacies.

Download PDF